Asebio Position Paper on Biosimilars (Spanish)

In recent decades, biotechnology has allowed the development of more than 650 innovative biological drugs to treat diseases such as cancer and other serious neurological, rheumatologic or endocrine diseases, among others.

This document tries to shed light on the complexity and specific characteristics of biological medicines and analyzes the degree of access of patients to these innovations in our country.

[Document only in Spanish]

Posicionamiento de Asebio sobre biosimilares.pdf469.86 KBDownload